Permanent Price Reductions

Author: APCI Staff/Tuesday, May 7, 2024/Categories: Generics and Vendor Contracting, Pricing

McKesson announced price reductions on the following items effective Friday, May 3, 2024:

ITEM NUM NDC NUM SELL DSCR OLD APCI PRICE NEW APCI PRICE $ Delta % Delta
1356161 51672129703 CLOBETAS E CR 0.05% TAR 60GM@ $124.01 $61.51 ($62.49) -50%
1374628 51672129701 CLOBETAS E CR 0.05% TARO 15GM@ $30.98 $20.89 ($10.09) -33%
1375187 51672129702 CLOBETAS E CR 0.05% TAR 30GM@ $61.49 $30.76 ($30.73) -50%
1501329 69238134603 TADALAFIL TB 2.5MG AMN 30@ $14.24 $7.59 ($6.65) -47%
1502780 00254302802 LUBIPROSTONE CP 8MCG PAR 60@ $205.75 $116.38 ($89.37) -43%
1502806 00254302902 LUBIPROSTONE CP 24MCG PAR 60@ $193.21 $166.25 ($26.97) -14%
1506625 16714007402 TADALAFIL TB 2.5MG NSTR UD30@ $11.94 $8.54 ($3.40) -28%
1559640 64980012460 DIFLORASONE OIN 0.05% RIS60GM@ $379.97 $356.25 ($23.72) -6%
1644855 00168026730 BETAMET DIP AUG LO .05%FO30ML@ $47.49 $35.14 ($12.35) -26%
1973148 68180031406 IMIPRAM PAM CAP 75MG LUPI 30@ $228.46 $142.49 ($85.97) -38%
2308005 16714015503 NORETHIN ACECP1MG/20MCG84NSTR@ $175.99 $149.72 ($26.27) -15%
2360378 49884015676 VARENICLINE TAB 1MG PAR 56@ $337.27 $154.35 ($182.92) -54%
2389708 72205008430 TIAGABINE HCL TB 2MG NOV30@ $112.09 $99.74 ($12.35) -11%
2425544 55111068102 FONDAP PFS 10MG/0.8ML DR/R 2@ $145.20 $99.74 ($45.45) -31%
2670636 68462012090 NICARDIPINE HCL CP 20MGGLEN90@ $741.01 $617.51 ($123.50) -17%
2883270 66689030516 SUCRALFATE OS1G/10ML PAI414ML@ $169.15 $161.50 ($7.66) -5%
3435500 68180086673 BLISOVI FE 1.5/30MGTB LUP3X28@ $26.59 $18.99 ($7.60) -29%
3681863 70710111108 TIZANIDINE HCL CAP 2MG ZYD150@ $95.00 $47.49 ($47.51) -50%
3687571 60505614804 CEFTRIAX INJ 1G/20ML APX 10@ $37.99 $27.54 ($10.45) -28%
3731841 00527458037 METHYLPH CD ER CP 20MGLANN100@ $227.05 $218.50 ($8.55) -4%
3794443 55150023310 FONDAP PFS 10MG/0.8ML AUR10@ $414.76 $256.50 ($158.26) -38%
3937232 51991090701 TETRACYC HCL CAP 500MGBREC100@ $275.50 $175.75 ($99.75) -36%
Tags:

Comments are only visible to subscribers.